CpG oligonucleotides increase HBV-specific cytokine responses in whole blood and enhance cytokine release assay sensitivity
- 1 October 2017
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 248, 195-201
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Eosinophilic EsophagitisNew England Journal of Medicine, 2015
- CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonistsJournal of Immunological Methods, 2014
- The Pathophysiology of Eosinophilic EsophagitisFrontiers in Pediatrics, 2014
- New therapeutic vaccination strategies for the treatment of chronic hepatitis BVirologica Sinica, 2014
- Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responsesJournal of Immunological Methods, 2013
- Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide AnaloguesGastroenterology, 2012
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicityVaccine, 2012
- T-cell responses to allergensJournal of Allergy and Clinical Immunology, 2007
- Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis BJournal of Hepatology, 2003